Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
cocaine hydrochloride
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial -
d-amphetamine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial -
d-amphetamine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
d-amphetamine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Use Disorder
1 trial -
delta 9 tetrahydrocannabinol
BRIGHT MINDS BIOSCIENCES INC.
COMT Gene Polymorphism
1 trial -
drug condition
BRIGHT MINDS BIOSCIENCES INC.
Cannabis
1 trial -
eszopiclone
BRIGHT MINDS BIOSCIENCES INC.
Marijuana Dependence
1 trial -
etrumadenant
Arcus Biosciences
GastroEsophageal Cancer
1 trial -
firibastat
Quantum Biopharma
Healthy Volunteers
1 trial -
forodesine hydrochloride
Biocryst
Cancer
1 trial -
galidesivir
Biocryst
Marburg Virus Disease
1 trial -
iTBS to the left dlPFC
BRIGHT MINDS BIOSCIENCES INC.
Chronic Pain
1 trial -
interceptive orthodontic treatments
NORTHWEST BIOTHERAPEUTICS INC
Malocclusion
1 trial -
interleukin-4 PE38KDEL cytotoxin
NEUROCRINE BIOSCIENCES INC
Breast Cancer
1 trial -
l-THP (l-tetrahydropalmatine)
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Use
1 trial -
locally manufactured adoptive cellular therapy (ACT) product
Iovance Biotherapeutics B.V.
Malignant Pleural Effusion
1 trial -
lofexidine HCl
BRIGHT MINDS BIOSCIENCES INC.
Renally Impaired Subjects
1 trial -
mHealth application (custom)
BRIGHT MINDS BIOSCIENCES INC.
Cognitive Function Abnormal
1 trial -
metyrapone & oxazepam
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Use Disorder
1 trial -
mitragynine
BRIGHT MINDS BIOSCIENCES INC.
Safety and Tolerability in Healthy Subjects
1 trial -
neratinib
PUMA BIOTECHNOLOGY, INC.
Healthy
5 trials -
neratinib
PUMA BIOTECHNOLOGY, INC.
Tumors
1 trial -
oral naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependence
1 trial -
pCAR-19B cells
Chongqing Precision Biotech Co., Ltd
Acute Lymphoblastic Leukemia, in Relapse
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources